Literature DB >> 20397269

Gender differences of low-dose aspirin-associated gastroduodenal ulcer in Japanese patients.

Kazuhisa Okada1, Masahiko Inamori, Kento Imajyo, Hideyuki Chiba, Takashi Nonaka, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiko Atsukawa, Hisao Takahashi, Etsuo Hoshino, Atsushi Nakajima.   

Abstract

AIM: To clarify the gender differences about the clinical features and risk factors of low-dose aspirin (LDA) (81-100 mg daily)-associated peptic ulcer in Japanese patients.
METHODS: There were 453 patients under treatment with LDA (298 males, 155 females) who underwent esophagogastroduodenoscopy at the Department of Gastroenterology and Hepatology of Hiratsuka City Hospital between January 2003 and December 2007. They had kept taking the LDA or started treatment during the study period and kept taking LDA during the whole period of observation. Of these, 119 patients (87 males, 32 females) were diagnosed as having LDA-associated peptic ulcer. We examined the clinical factors associated with LDA-associated peptic ulcer in both sexes.
RESULTS: A history of peptic ulcer was found to be the risk factor for LDA-associated peptic ulcer common to both sexes. In female patients, age greater than 70 years (prevalence ORs 8.441, 95% CI: 1.797-33.649, P = 0.0069) was found to be another significant risk factor, and the time to diagnosis as having LDA-associated peptic ulcer by endoscopy was significantly shorter than that in the male patients (P = 0.0050).
CONCLUSION: We demonstrated gender differences about the clinical features and risk factors of LDA-associated peptic ulcer. Special attention should be paid to aged female patients taking LDA.

Entities:  

Keywords:  Gender; Low-dose aspirin; Peptic ulcer

Mesh:

Substances:

Year:  2010        PMID: 20397269      PMCID: PMC2856832          DOI: 10.3748/wjg.v16.i15.1896

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Influence of gender difference and gastritis on gastric ulcer formation in rats.

Authors:  E S Liu; B C Wong; C H Cho
Journal:  J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 4.029

Review 2.  Gastrointestinal effects of nonsteroidal anti-inflammatory therapy.

Authors:  J B Raskin
Journal:  Am J Med       Date:  1999-05-31       Impact factor: 4.965

3.  Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients.

Authors:  Kazuhisa Okada; Masahiko Inamori; Kento Imajo; Hideyuki Chiba; Takashi Nonaka; Tadahiko Shiba; Takashi Sakaguchi; Kazuhiro Atsukawa; Hisao Takahashi; Etsuo Hoshino; Atsushi Nakajima
Journal:  Hepatogastroenterology       Date:  2009 Nov-Dec

4.  Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans.

Authors:  B Cryer; M Feldman
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

5.  Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.

Authors:  H T Sørensen; L Mellemkjaer; W J Blot; G L Nielsen; F H Steffensen; J K McLaughlin; J H Olsen
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

6.  Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin.

Authors:  A Lanas; J Fuentes; R Benito; P Serrano; E Bajador; R Sáinz
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

7.  Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data.

Authors:  S C Lewis; M J S Langman; Joan-Ramon Laporte; John N S Matthews; Michael D Rawlins; Bengt-Erik Wiholm
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

Review 8.  Peptic ulcer disease in pregnancy.

Authors:  P A Michaletz-Onody
Journal:  Gastroenterol Clin North Am       Date:  1992-12       Impact factor: 3.806

9.  Effects of exogenous administration of female sex hormones on gastric secretion and ulcer formation in the rat.

Authors:  C N Aguwa
Journal:  Eur J Pharmacol       Date:  1984-09-03       Impact factor: 4.432

10.  Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases.

Authors:  P Serrano; A Lanas; M T Arroyo; I J Ferreira
Journal:  Aliment Pharmacol Ther       Date:  2002-11       Impact factor: 8.171

View more
  6 in total

Review 1.  The roles of estrogen and estrogen receptors in gastrointestinal disease.

Authors:  Changmei Chen; Xiang Gong; Xiaoxu Yang; Xianhui Shang; Qian Du; Qiushi Liao; Rui Xie; Yuanshou Chen; Jingyu Xu
Journal:  Oncol Lett       Date:  2019-10-11       Impact factor: 2.967

2.  Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury.

Authors:  Yoshitsugu Ito; Makoto Sasaki; Seiji Noguchi; Sumiharu Yamaguchi; Noriko Okaniwa; Atsushi Tanabe; Hisatsugu Noda; Kenichiro Yanamoto; Yasuhiro Tamura; Yoshihiro Kondo; Ryuta Masui; Shinya Izawa; Akihito Iida; Mari Mizuno; Naotaka Ogasawara; Yasushi Funaki; Kunio Kasugai
Journal:  United European Gastroenterol J       Date:  2013-08       Impact factor: 4.623

Review 3.  Role of estrogen receptors in health and disease.

Authors:  Peng Chen; Bo Li; Ling Ou-Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

4.  Human monocytes respond to lipopolysaccharide (LPS) stimulation in a sex-dependent manner.

Authors:  Ilaria Campesi; Andrea Montella; Flavia Franconi
Journal:  J Cell Physiol       Date:  2021-07-12       Impact factor: 6.513

5.  Effect of ovarian sex hormones on non-steroidal anti-inflammatory drug-induced gastric lesions in female rats.

Authors:  Tultul K Sangma; Seema Jain; Pramod K Mediratta
Journal:  Indian J Pharmacol       Date:  2014 Jan-Feb       Impact factor: 1.200

6.  Relationship between Hormonal Modulation and Gastroprotective Activity of Malvidin and Cyanidin Chloride: In Vivo and In Silico Approach.

Authors:  Melina Luzzi Zarricueta; Felipe Leonardo Fagundes; Quélita Cristina Pereira; Simone Queiroz Pantaleão; Raquel de Cássia Dos Santos
Journal:  Pharmaceutics       Date:  2022-03-04       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.